220.57
Bio Rad Laboratories Inc stock is traded at $220.57, with a volume of 374.09K.
It is up +1.85% in the last 24 hours and down -6.67% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$216.56
Open:
$215.75
24h Volume:
374.09K
Relative Volume:
1.01
Market Cap:
$4.88B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-8.0706
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-4.25%
1M Performance:
-6.67%
6M Performance:
-33.62%
1Y Performance:
-23.67%
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BIO
Bio Rad Laboratories Inc
|
220.57 | 6.27B | 2.58B | -778.69M | 223.75M | -27.33 |
![]()
ABT
Abbott Laboratories
|
133.71 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
103.10 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
381.01 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
85.54 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.72 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jun-03-24 | Resumed | Jefferies | Hold |
Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
Dec-07-23 | Initiated | UBS | Buy |
Jun-16-23 | Initiated | Wells Fargo | Overweight |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Jan-28-22 | Reiterated | Citigroup | Buy |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Oct-17-18 | Initiated | Goldman | Buy |
Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
Feb-16-18 | Downgrade | CL King | Buy → Neutral |
Jul-13-17 | Initiated | Wells Fargo | Outperform |
Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
Jan-18-17 | Initiated | Deutsche Bank | Hold |
Oct-13-16 | Initiated | CL King | Buy |
May-06-15 | Reiterated | Jefferies | Buy |
Dec-18-09 | Initiated | Maxim Group | Buy |
Nov-06-09 | Initiated | Jefferies & Co | Buy |
Jul-17-09 | Initiated | Soleil | Buy |
Sep-26-07 | Initiated | Banc of America Sec | Buy |
Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Epigenetics Market Anticipated to Achieve 11.8% CAGR - GlobeNewswire Inc.
Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com
High Resolution Melting Analysis Market Detailed in New - openPR.com
Gel Documentation Systems Market Projected to Witness Massive - openPR.com
Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com
Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Protein Characterization and Identification Market Is Booming WorldwideBio-Rad Laboratories, Agilent Technologies - openPR.com
Electrophoresis Reagents Market Detailed in New Research ReportBio-Rad Laboratories, Thermo Fisher Scientific - openPR.com
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference | BIO Stock News - GuruFocus
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
Cell Analysis Market Deep Research Report Highlights New DevelopmentsBD Biosciences, Bio-Rad - openPR.com
Hemoglobin A1c Testing Devices Market To Witness Substantial - openPR.com
Difficult-to-Express Proteins Market Expansion Driven - openPR.com
Salmonella Testings Market to Witness Stunning Growth with Thermo Fisher, Bio-Rad, Merck - openPR.com
Flow Cytometry Market Deep Research with Forecast By 2025-2032 | - openPR.com
Protein Assays Market Set to Witness Significant Growth - openPR.com
Enzyme Linked Immunosorbent Assay Market Survey Detailed - openPR.com
Global Clinical Microbiology Market Trends, Growth & Analysis - openPR.com
Medical Biosensors Market 2025 | Latest Trends, Growth Forecast - openPR.com
Bio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growth - Investing.com Canada
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges - Investing.com Australia
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Stock Price Down 4.42% on May 21 - GuruFocus
Polymerase Chain Reaction Market Deep Research Report with - openPR.com
Multiplex assays Market Set to Witness Significant Growth - openPR.com
Protein Chip Industry Forecast: Clean Ingredients, - openPR.com
Bio-rad outlines updated 2025 guidance amid academic and macro challenges - MSN
Karyotype Market Size, Growth Analysis 2031 by Key Vendors- - openPR.com
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket - MSN
Cytogenetic Systems Market Accelerates Owing to Increased - openPR.com
RNA Analysis Transcriptomics Market Top PlayersAgilent - openPR.com
Polyclonal Antibody Market Growth, Trends & Forecast 2025-2033 - openPR.com
Syphilis Immunoassay Diagnostics Market Detailed in New - openPR.com
Serum Market Is Booming Worldwide 2025-2032 | Thermo Fisher - openPR.com
Multiplex Assays Market Is Booming Worldwide 2025-2032 | Bio-Rad Laboratories, Inc.,Thermo Fisher Scientific - openPR.com
Microplate Systems Market Experiencing Steady Growth - openPR.com
Vector Purification Market 2025: Growth, Applications, - openPR.com
Enzyme Linked Immunosorbent Assay Market Set to Witness - openPR.com
Digital PCR Market in Research By 2031 | Most Leading Companies - openPR.com
Onco-hematology Molecular Testing Market Top Players - openPR.com
Protein Engineering Market Detailed In New Research Report 2025 - openPR.com
Transfection Technologies Market Competitive Growth - openPR.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):